Prospects for a mucosally-administered vaccine against Helicobacter pylori.
Svennerholm
Ann-Mari
AM
Department of Medical Microbiology and Immunology, Göteborg University Research Institute (GUVAX), Göteborg University, PO Box 435, 40530, Göteborg, Sweden. ann-mari.svennerholm@microbio.gu.se
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000276:immunology; D004386:Duodenum / Q000276:immunology; D016481:Helicobacter Infections / Q000276:immunology / Q000517:prevention & control; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D018928:Immunity, Mucosal / Q000276:immunology*; D013270:Stomach / Q000276:immunology
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines